Author Interviews, Heart Disease, JAMA, Pediatrics / 14.08.2019
Predicting Sudden Death in Children with Hypertrophic Cardiomyopathy
MedicalResearch.com Interview with:
Dr Juan Pablo Kaski MD(Res) FRCP FESC
Director of the GOSH Centre for Inherited Cardiovascular Diseases
Great Ormond Street Hospital,
University College London Institute of Cardiovascular Science,
London, UK
MedicalResearch.com: What is the background for this study? Would you briefly explain what is meant by Hypertrophic Cardiomyopathy?
Response: Hypertrophic cardiomyopathy (HCM) is a genetic condition characterised by abnormal thickening of the muscle of the heart and can affect people of all ages. It is associated with an increased risk of sudden cardiac death (SCD) and, in the last few years, a clinical risk tool that estimates the 5-year risk of SCD in adults with HCM has been developed.
However, there are no similar risk models in children, where risk stratification has traditionally been based on clinical risk factors extrapolated from the adult population. We have recently shown that this approach does not discriminate risk well in children, and so the aim of this study was to develop a new risk tool to provide an individualised risk of SCD in children with HCM. (more…)